Abstract

082 Interleukin-1β IL-1 receptor antagonist levels in subacute sclerosing panencephalitis patients and effects of different treatment protocols

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call